CymitQuimica logo

CAS 49763-96-4

:

Stiripentol

Description:
Stiripentol is an anticonvulsant medication primarily used in the treatment of epilepsy, particularly in patients with Dravet syndrome, a severe form of epilepsy. It is classified as a benzodioxole derivative and functions by enhancing the activity of gamma-aminobutyric acid (GABA), a neurotransmitter that inhibits neuronal excitability. Stiripentol is known for its ability to increase the effectiveness of other antiepileptic drugs, particularly clobazam, and is often used in combination therapy. The substance has a relatively low solubility in water, which can affect its bioavailability. Its pharmacokinetics involve hepatic metabolism, and it is primarily excreted through the urine. Common side effects may include sedation, loss of appetite, and gastrointestinal disturbances. Due to its specific therapeutic applications and interactions with other medications, stiripentol is typically prescribed under careful medical supervision. As with any medication, monitoring for efficacy and adverse effects is essential to ensure optimal treatment outcomes for patients with epilepsy.
Formula:C14H18O3
InChI:InChI=1S/C14H18O3/c1-14(2,3)13(15)7-5-10-4-6-11-12(8-10)17-9-16-11/h4-8,13,15H,9H2,1-3H3
InChI key:InChIKey=IBLNKMRFIPWSOY-UHFFFAOYSA-N
SMILES:C(=CC(C(C)(C)C)O)C=1C=C2C(=CC1)OCO2
Synonyms:
  • (1E)-1-(1,3-benzodioxol-5-yl)-4,4-dimethylpent-1-en-3-ol
  • 1-(1,3-Benzodioxol-5-Yl)-4,4-Dimethylpent-1-En-3-Ol
  • 1-(1,3-Benzodioxol-5-yl)-4,4-dimethyl-1-penten-3-ol
  • 1-Penten-3-ol, 1-(1,3-benzodioxol-5-yl)-4,4-dimethyl-
  • 256-480-9
  • 4,4-Dimethyl-1-(3,4-methylenedioxyphenyl)-1-penten-3-ol
  • Bcx 2600
  • Diacomit
  • Stiripentol
Sort by

Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 11 products.
  • Stiripentol

    CAS:
    Formula:C14H18O3
    Purity:98%
    Color and Shape:Solid
    Molecular weight:234.2909

    Ref: IN-DA00D90N

    1g
    75.00€
    5g
    208.00€
    250mg
    40.00€
  • Stiripentol

    CAS:
    Stiripentol
    Purity:≥98%
    Molecular weight:234.29g/mol

    Ref: 54-BUP15392

    5mg
    76.00€
    10mg
    114.00€
    25mg
    220.00€
    50mg
    299.00€
    100mg
    495.00€
    200mg
    722.00€
  • 1-(Benzo[d][1,3]Dioxol-5-Yl)-4,4-Dimethylpent-1-En-3-Ol

    CAS:
    1-(Benzo[d][1,3]Dioxol-5-Yl)-4,4-Dimethylpent-1-En-3-Ol
    Purity:99%
    Molecular weight:234.29g/mol

    Ref: 54-OR1008962

    1g
    72.00€
    5g
    277.00€
    25g
    1,209.00€
    100g
    4,226.00€
    250mg
    34.00€
  • Stiripentol

    CAS:
    Formula:C14H18O3
    Purity:≥ 98.0%
    Color and Shape:White to off-white powder or solid
    Molecular weight:234.29

    Ref: 7W-GP3535

    50mg
    156.00€
    250mg
    370.00€
  • Stiripentol

    CAS:
    Formula:C14H18O3
    Purity:>98.0%(GC)
    Color and Shape:White to Almost white powder to crystal
    Molecular weight:234.30

    Ref: 3B-S0905

    1g
    175.00€
    5g
    599.00€
  • Stiripentol Impurity 12 (E/Z Mixture)

    CAS:
    Formula:C14H18O3
    Molecular weight:234.30

    Ref: 4Z-S-058030

    5mg
    To inquire
    10mg
    To inquire
    25mg
    To inquire
    50mg
    To inquire
    100mg
    To inquire
  • Stiripentol

    CAS:
    Stiripentol (BCX2600) (STP) is an anticonvulsant agent, which can inhibit N-demethylation of CLB to NCLB mediated by CYP3A4 (noncompetitively) and CYP2C19 (
    Formula:C14H18O3
    Purity:99.87% - >99.99%
    Color and Shape:White Solid
    Molecular weight:234.29
  • Stiripentol

    Controlled Product
    CAS:
    <p>Applications An epilepsy drug. It has been used as co-therapy for treatment of epilepsy. It inhibits the enzymes responsible for metabolism of other anti-convulsant agents.<br>References Laurie, D., et al.: J. Neurosci., 12, 4151 (1992), Smith, A., et al.: J. Pharmacol. Exp. Therap., 311, 601 (2004), Trojnar, M., et al.: Pharm. Rep., 57, 154 (2005), Drafts, B., et al.: J. Pharm. Exp. Ther., 318, 1094 (2006), Picton, A., et al.: Brain Res., 1165, 40 (2007),<br></p>
    Formula:C14H18O3
    Color and Shape:Light Yellow Solid
    Molecular weight:234.29

    Ref: TR-S686825

    50mg
    210.00€
    100mg
    286.00€
    250mg
    717.00€
  • 4,4-Dimethyl-1-[(3,4-methylenedioxy)phenyl]-1-penten-3-ol

    CAS:
    <p>4,4-Dimethyl-1-[(3,4-methylenedioxy)phenyl]-1-penten-3-ol is a drug that has been used in the treatment of Dravet syndrome. This drug is also known as 3,4-methylenedioxyphenylacetone. It is a competitive inhibitor of the enzyme citrate synthase and inhibits the conversion of acetate to citrate. The effect of 4,4-dimethyl-1-[(3,4-methylenedioxy)phenyl]-1-penten-3-ol on sodium citrate concentrations is concentration dependent and results in an increase in plasma sodium concentrations with prolonged administration. Other drugs that are metabolized by the cytochrome P450 system may interact with 4,4-dimethyl-1-[(3,4 methylenedioxy)phenyl]-1 penten 3 ol and lead to increased levels of these drugs in the blood.</p>
    Formula:C14H18O3
    Purity:Min. 95%
    Color and Shape:White Powder
    Molecular weight:234.29 g/mol

    Ref: 3D-FS27881

    1g
    454.00€
    2g
    717.00€
    100mg
    144.00€
    250mg
    218.00€
    500mg
    350.00€
  • Stiripentol

    CAS:
    Formula:C14H18O3
    Purity:98%
    Color and Shape:Solid
    Molecular weight:234.295

    Ref: 10-F505617

    1g
    80.00€
    5g
    307.00€
  • Stiripentol-13C3

    Controlled Product
    CAS:
    Formula:C3C11H18O3
    Color and Shape:Neat
    Molecular weight:237.269

    Ref: TR-S686822

    75mg
    26,275.00€